Cambridge - Intertek, a Total Quality Assurance provider to industries worldwide, today announced the further expansion of its UK GMP (Good Manufacturing Practice) pharmaceutical stability storage facility to a capacity of 250,000 litres. The 10,000 ft², Royston-based facility, one of the largest in Europe, was launched in May 2015 to broaden the range of solutions Intertek can offer to the global pharmaceutical industry.
Since the opening of the facility near Cambridge, in the heartland of the UK's pharmaceutical and biotechnology industry, a growing number of clients across the pharmaceutical industry and other sectors such as medical devices, cosmetics, speciality chemicals and consumer healthcare, have expressed a need for increased stability storage. This expanded facility enables Intertek to offer a wider range of bespoke storage conditions alongside the typical ICH conditions, to meet the needs of a global client base.
The expansion is also due to an increased demand for disaster recovery storage, contingency storage programmes and ‘storage-only’ projects where a GMP outsourcing partner is critical to mitigating risks associated with the lifecycle of pharmaceutical products. These risks include potential loss of valuable products that have been in stability storage for a number of years, disruption to the continuation and integrity of the stability trial and disruption to operations, downtime and productivity.
Intertek UK & Eire Chief Executive Rob van Dorp said “We continue to expand our Royston site, one of Europe’s largest GMP pharmaceutical stability storage facilities, with the aim of becoming the largest in Europe, as demand grows for off-site storage from our global clients. This latest expansion brings increased capacity and flexibility providing superior customer service for our clients in Europe and globally. Integrated with the teams’ outstanding expertise in analytical and formulation support for the pharmaceutical, biotechnology and drug delivery industries, we can effectively help our clients to mitigate risks and meet milestones for their challenging pharmaceutical development programmes through superior quality assurance solutions.”
GMP stability testing forms a key part of Intertek’s pharmaceutical development services. Intertek’s global International Conference on Harmonisation (ICH) stability storage and testing locations also include Manchester (UK), Whitehouse, (New Jersey, USA) and Melbourne, (Australia). Intertek has a 20-year heritage providing cGMP contract analytical, bioanalytical, stability and formulation support, as well as regulatory affairs services.
Total Quality. Assured.
Intertek is a leading Total Quality Assurance provider to industries worldwide. Our network of more than 1,000 laboratories and offices and over 42,000 people in more than 100 countries, delivers innovative and bespoke Assurance, Testing, Inspection and Certification solutions for our customers’ operations and supply chains. Intertek Total Quality Assurance expertise, delivered consistently with precision, pace and passion, enabling our customers to power ahead safely.
UK PR Manager
Dr. Lorna Kettle
Marketing & Communications – Pharmaceutical Services
+44 161 721 1476